| HOME >> MEDICINE >> TECHNOLOGY |
- Conference Call/Webcast To Be Held Today at 10:00 a.m. EDT -
TARRYTOWN, N.Y., Aug. 7 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced its financial results for the second quarter ended June 30, 2007.
"Emisphere's product pipeline is growing increasingly robust," said Michael V. Novinski, President/Chief Executive Officer of Emisphere Technologies, Inc. "In addition to the 10 products we have in various stages of clinical development, we have an additional 11 pre-clinical projects in our pipeline, six with partners and five without established collaborations. We are seeking to move our patented technology into a broad array of disease states, including obesity, osteoporosis, infectious disease, diabetes, CNS, erectile dysfunction and fertility treatment, among others."
Emisphere Technologies, Inc. will host a conference call to discuss second quarter results at 10:00 AM EDT today. A live Webcast of the conference call can be accessed through the company's Web site at: http://www.emisphere.com. The live conference call dial-in number is: 1-800-819-9193 (US and Canada) or 1- 913-981-4911 (International). In addition, an archive of the Webcast can be accessed through the same link; an audio replay of the call will be available following the conference call by calling 1-888-203-1112 (US and Canada) or 1- 719-457-0820 (International). The conference replay PIN is 9045496.
Second Quarter Financial Results
-- Operating expenses for the second quarter of 2007 were $9.9 million
compared to $8.6 million in the second quarter of 2006
* $1.3 million increase in operating expenses is prim
'/>"/>
SOURCE Emisphere Technologies, Inc.![]() Copyright©2007 PR Newswire. |